Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ERN1 | O75460 | 9/20 | 0.54 |
| ▸ | NR1H4 | Q96RI1 | 2/20 | 0.46 |
| ▸ | CA1 | P00915 | 1/20 | 0.43 |
| ▸ | CA2 | P00918 | 1/20 | 0.43 |
| ▸ | TRIM24 | O15164 | 1/20 | 0.42 |
| ▸ | TYR | P14679 | 1/20 | 0.42 |
| ▸ | TRIM33 | Q9UPN9 | 1/20 | 0.42 |
| ▸ | SENP1 | Q9P0U3 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | GABRA3 | P34903 | 1/20 | 0.41 |
| ▸ | GABRA2 | P47869 | 1/20 | 0.41 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21511144 | 0.91 | ERN1 (0.54) | ERN1NR1H4CA1CA2MEN1 | |
| SCHEMBL7030208 | 0.88 | KMT2A (0.57) | ERN1CA2MEN1MAPTKMT2A | |
| SCHEMBL21499770 | 0.79 | ESR1 (0.50) | ERN1TRIM24TYRTRIM33MEN1 | |
| SCHEMBL3887594 | 0.78 | ERN1 (0.62) | ERN1TRIM24TYRTRIM33MEN1 | |
| SCHEMBL28147777 | 0.78 | NSD2 (0.57) | ERN1TRIM24TRIM33MEN1MAPT | |
| SCHEMBL2727720 | 0.78 | KMT2A (0.57) | CA2TRIM24TYRTRIM33MEN1 | |
| SCHEMBL777824 | 0.78 | KMT2A (0.65) | CA1CA2SENP1MEN1MAPT | |
| SCHEMBL767555 | 0.78 | NR1H4 (0.55) | NR1H4CA1CA2SENP1MEN1 | |
| SCHEMBL766699 | 0.78 | ESR1 (0.50) | NR1H4CA1CA2SENP1MEN1 | |
| SCHEMBL767381 | 0.78 | NR1H4 (0.48) | NR1H4CA1CA2SENP1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200283399-A1 | METHOD OF PRODUCING POLYMERIZABLE COMPOUND, AND SOLUTION OF POLYMERIZABLE COMPOUND | ZEON CORPORATION (JP) | 2020-09-10 | — | — | US | disclosed |
| EP-3604289-A1 | POLYMERIZABLE COMPOUND PRODUCTION METHOD AND POLYMERIZABLE COMPOUND SOLUTION | Zeon Corporation (JP) | 2020-02-05 | — | — | EP | disclosed |
| US-20190322872-A1 | POLYMERIZABLE COMPOUND, POLYMERIZABLE COMPOSITION, POLYMER, OPTICAL FILM, OPTICALLY ANISOTROPIC BODY, POLARIZER, FLAT PANEL DISPLAY, ORGANIC ELECTROLUMINESCENCE DISPLAY, ANTIREFLECTION FILM, AND COMPOUND | ZEON CORPORATION (JP) | 2019-10-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190322872-A1 | POLYMERIZABLE COMPOUND, POLYMERIZABLE COMPOSITION, POLYMER, OPTICAL FILM, OPTICALLY ANISOTROPIC BODY, POLARIZER, FLAT PANEL DISPLAY, ORGANIC ELECTROLUMINESCENCE DISPLAY, ANTIREFLECTION FILM, AND COMPOUND | H1-0, H1-4, H1-10 | ERN1 3024/4885NR1H4 517/4885CA1 2425/4885 |
| US-20200283399-A1 | METHOD OF PRODUCING POLYMERIZABLE COMPOUND, AND SOLUTION OF POLYMERIZABLE COMPOUND | PDE8A, ADCY6, TKFC | ERN1 1631/4885NR1H4 4152/4885CA1 1325/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.